Anand K Kondapi

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Radical Prostatectomy

Benign Prostatic Hyperplasia

Prostate Cancer

Top Venues

Nanomedicine (London, England)

Cancer chemotherapy and pharmacology

University of Hyderabad

Andhra University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Hyderabad Dec 02 2006

India

Professor :: Department of Biotechnology and Bioinformatics

University of Hyderabad Oct 03 2000 - Dec 02 2006

India

Reader :: Department of Biochemistry

University of Hyderabad Jun 21 1998 - Oct 02 2000

India

Lecturer (senior scale) :: Department of Biochemistry

University of Hyderabad Jun 21 1993 - Jun 20 1998

India

Lecturer :: Department of Biochemistry

Indian Institute of Science Jan 01 1990 - Jun 20 1993

India

Research Associate :: Department of Biochemistry

Education History

Andhra University Jun 15 1985 - May 15 1990

India

PHD :: School of Chemistry

Publications

Chukhu Muj, Satyajit Mukhopadhyay, Pritikana Jana, Anand K Kondapi
Synergistic action of lactoferrin in enhancing the safety and effectiveness of docetaxel treatment against prostate cancer. Cancer chemotherapy and pharmacology (2023)
Samrajya Lakshmi Yeruva, Prashant Kumar, Seetharam Deepa, Anand K Kondapi
Lactoferrin nanoparticles coencapsulated with curcumin and tenofovir improve vaginal defense against HIV-1 infection. Nanomedicine (London, England) 16 (7) (2021)
Radhakrishna Muttineni, Nagamani Kammili, Thrilok Chander Bingi, Raja Rao M, Kalyani Putty, Pankaj Singh Dholaniya, Ravi Kumar Puli, Sunitha Pakalapati, Saritha S, Shekar K, Mallikarjuna Reddy Doodipala, Amit A Upadhyay, Steven E Bosinger, Rama R Amara, Anand K Kondapi
Clinical and whole genome characterization of SARS-CoV-2 in India. PloS one 16 (2) (2021)
Anand K Kondapi
Targeting cancer with lactoferrin nanoparticles: recent advances. Nanomedicine (London, England) 15 (21) (2020)